Stamford, CT -- (SBWIRE) -- 01/25/2014 -- High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Open Text Corporation (USA)(NASDAQ:OTEX), CNO Financial Group Inc(NYSE:CNO), Celldex Therapeutics, Inc.(NASDAQ:CLDX), Diamond Offshore Drilling Inc(NYSE:DO)
Open Text Corporation (USA)(NASDAQ:OTEX) opened the session at $99.67, remained amid the day range of $98.79 - $104.21, and closed the session at $100.16. The stock showed a positive performance of +10.53% in previous trading session. The stock gained a volume of 2.37 million shares and the average volume of the stock remained 292,678.00 shares. Open Text Corporation engages in the design, development, marketing, and sale of enterprise information management software and solutions.
Why Should Investors Buy OTEX After The Recent Gain? Just Go Here and Find Out
CNO Financial Group Inc(NYSE:CNO) traded with volume of 2.36 million shares in the prior session and the average volume of the stock remained 1.36 million shares. The 52 week range of the stock remained $9.94 - $18.33. The stock showed a negative movement of -4.64% and closed its session at $17.07. The market capitalization of the stock remained 3.79 billion. CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States.
Why Should Investors Buy CNO After the Recent Fall? Just Go Here and Find Out
Celldex Therapeutics, Inc.(NASDAQ:CLDX) exchanged 2.36 million shares and the average volume remained 2.12 million shares. The stock dropped -6.99% and closed the session at $27.14. The beta of the stock remained 1.99 and the EPS of the stock remained -1.02. The shares outstanding of the stock remained 89.16 million. Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States.
Has CLDX Found The Bottom And Ready To Gain Momentum? Find Out Here
Diamond Offshore Drilling Inc(NYSE:DO) gained volume of 2.35 million shares, while the average volume remained 1.38 million shares. The stock decreased -1.62% and finished the session Friday at $51.04. The EPS of the stock remained 4.40. The one month of the stock was -9.04% and three month trend remained negative -16.27%. Diamond Offshore Drilling, Inc. operates as an offshore oil and gas drilling contractor worldwide.
Has DO Found The Bottom and Ready To Move Up? Find Out Here
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. It carries Hot Penny Stocks and Penny Stock Newsletter, we will send you alerts through our Free Penny Stock Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)